Literature DB >> 19160111

Morgagni on apoplexy in De Sedibus: a historical perspective.

Henry S Schutta1.   

Abstract

This paper considers the historical significance of case reports on apoplexy and paralysis in Morgagni's De Sedibus et Causis Morborum. When autopsies became relatively common in the sixteenth century, Galen's speculation that apoplexy was caused by the accumulation of cold phlegm or black bile in the cerebral ventricles began to be questioned and was largely abandoned in the following century. The notion that the seats and causes of diseases are to be found in solid organs and not in the dyscrasia of humors gradually replaced many but not all humoral concepts. Morgagni's letters on apoplexy bolstered this "solidist" idea, but humoral physiology was still employed as a foundation for the treatment of apoplexy and to explain some aspects of the pathogenesis of this syndrome. Based on autopsy studies, Morgagni considered two principal forms of apoplexy, due to intracranial hemorrhage ("sanguineous apoplexy") and excessive intracranial fluid ("serous apoplexy"), to which he added a group that he judged to be separate from these two archetypes.

Entities:  

Mesh:

Year:  2009        PMID: 19160111     DOI: 10.1080/09647040701578219

Source DB:  PubMed          Journal:  J Hist Neurosci        ISSN: 0964-704X            Impact factor:   0.529


  4 in total

1.  Giovanni Battista Morgagni (1682-1771).

Authors:  Çağatay Öncel; Sevin Baser
Journal:  J Neurol       Date:  2015-10-20       Impact factor: 4.849

2.  The definition of stroke.

Authors:  Alexander P Coupland; Ankur Thapar; Mahim I Qureshi; Harri Jenkins; Alun H Davies
Journal:  J R Soc Med       Date:  2017-01-13       Impact factor: 5.344

Review 3.  Historic review: select chapters of a history of stroke.

Authors:  Axel Karenberg
Journal:  Neurol Res Pract       Date:  2020-12-01

4.  tPA for Acute Ischemic Stroke and Its Controversies: A Review.

Authors:  Brian Dewar; Michel Shamy
Journal:  Neurohospitalist       Date:  2019-04-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.